文献速递眼底病与葡萄膜炎

玻璃体切除联合视网膜下组织型纤溶酶原激活剂治疗黄斑下出血后发生孔源性视网膜脱离

RHEGMATOGENOUS RETINAL DETACHMENT AFTER VITRECTOMY AND SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR FOR SUBMACULAR HEMORRHAGE.
PubMed 文献 · Retina · 2025-01-01

该研究回顾2014年4月1日至2023年9月1日因黄斑下出血行玻璃体切除联合视网膜下组织型纤溶酶原激活剂治疗的167只眼,15只眼(9%)发生孔源性视网膜脱离,其中12只眼(80%)伴黄斑脱离、9只眼(60%)伴增生性玻璃体视网膜病变;最终视网膜复位解剖成功率为92%(12/13)。

要点

  • 167只眼中15只眼(9%)在术后发生孔源性视网膜脱离,中位诊断时间为41天(IQR 22-81)。
  • 发生视网膜脱离的眼中12只眼(80%)伴黄斑脱离、9只眼(60%)伴增生性玻璃体视网膜病变。
  • 13只眼行视网膜脱离修复,最终复位解剖成功率为92%(12/13),4只眼(27%)再脱离。

核心结论

  • 黄斑下出血行玻璃体切除联合视网膜下组织型纤溶酶原激活剂治疗后,近十分之一眼发生术后孔源性视网膜脱离,并与较高的增生性玻璃体视网膜病变发生率相关。

研究设计与样本

  • 回顾性病历审查,纳入2014年4月1日至2023年9月1日期间因黄斑下出血接受玻璃体切除联合视网膜下组织型纤溶酶原激活剂治疗的167只眼。

主要发现

  • 167只眼中15只眼(9%)发生孔源性视网膜脱离,其中12只眼(80%)伴黄斑脱离、9只眼(60%)伴增生性玻璃体视网膜病变。
  • 从玻璃体切除联合视网膜下组织型纤溶酶原激活剂至诊断孔源性视网膜脱离的中位时间(IQR)为41天(22-81)。
  • 13只眼行孔源性视网膜脱离修复,2只眼因视力预后差观察;术后3个月单次手术解剖成功11只眼(85%),末次随访时9只眼(70%)。
  • 4只眼(27%)发生再脱离,3只眼接受中位2次额外修复;最终复位解剖成功率为92%(12/13)。
  • 黄斑下出血后术前中位(IQR)logMAR视力为2(2-2.3)[Snellen 20/2,000],诊断孔源性视网膜脱离时恶化至2.3(2.2-2.7)[20/4,000](P=0.01),末次随访时稳定于2.3(2-2.7)[20/4,000](P=0.15)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the incidence and outcomes of rhegmatogenous retinal detachment (RRD) occurring after pars plana vitrectomy and subretinal tissue plasminogen activator for submacular hemorrhage (SMH). METHODS: Charts were reviewed between April 1, 2014, and September 1, 2023, for eyes that underwent pars plana vitrectomy/subretinal tissue plasminogen activator for SMH. RESULTS: Of 167 eyes, 15 eyes (9%) developed RRD with macular detachment in 12 eyes (80%) and proliferative vitreoretinopathy (PVR) in nine eyes (60%). The median (interquartile range, IQR) time from pars plana vitrectomy/subretinal tissue plasminogen activator until RRD diagnosis was 41 days (22-81). Thirteen eyes underwent RRD repair and two eyes were observed due to poor visual prognosis. Single-surgery anatomical success was achieved in 11 eyes (85%) at three months and nine eyes (70%) at the final visit. Four eyes (27%) developed redetachment, and three eyes underwent a median of two additional repairs. The final anatomical success rate for reattachment was 92% (12/13). The median (IQR) logarithm of the minimal angle of resolution [Snellen] visual acuity at the preoperative visit after SMH was 2 (2-2.3) [20/2,000], which worsened to 2.3 (2.2-2.7) [20/4,000] at the time of RRD diagnosis ( P = 0.01) and plateaued by the final visit to 2.3 (2-2.7) [20/4,000] ( P = 0.15). CONCLUSION: Postoperative RRD occurred in nearly one in 10 eyes after pars plana vitrectomy/subretinal tissue plasminogen activator for SMH and was associated with a relatively high rate of PVR.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Safran JP, Momenaei B, Martin J, et al. RHEGMATOGENOUS RETINAL DETACHMENT AFTER VITRECTOMY AND SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR FOR SUBMACULAR HEMORRHAGE. Retina. 2025. PMID: 39903912. doi:10.1097/IAE.0000000000004417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。